Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls

Digestive Diseases and Sciences

Volumn 41, Issue 11, 1996, Pages 2115-2122

  Hirschowitz, Basil I ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Associated hiatal hernia; Body mass index; Body weight; Duodenal ulcer; Esophageal stricture; Gastric secretion; Gastric surgery; Zollinger Ellison syndrome

Indexed keywords

PEPSIN A;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DUODENUM ULCER; ENDOSCOPY; ESOPHAGUS STRICTURE; FEMALE; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH ACID SECRETION; STOMACH SURGERY; ZOLLINGER ELLISON SYNDROME;

EID: 0029826315     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02071389     Document Type: Article

References (50)

1. Marks RD, Richter JE: Peptic strictures of the esophagus. Am J Gastroenterol 88:1160-1173, 1993
2. McCord GS, Clouse RE: Pill-induced esophageal strictures: Clinical features and risk factors for development. Am J Mcd 88:512-518, 1990
3. Bozymski EM, Isaacs KL: Miscellaneous diseases of the esophagus. In: Textbook of Gastroenterology, 2nd ed. T Yamada, DH Alpers, C Owyang, DW Powell, FE Silverstein (eds). Philadelphia, JB Lippincott, 1995, pp 1283-1302
4. Terblanche J, Khan D, Bornman P: Long-term injection sclerotherapy treatment for esophageal varices: A 10-year prospective evaluation. Ann Surg 210:725-731, 1989
5. Fine J-D: Management of acquired bullous skin diseases. N Engl J Med 333:1475-1484, 1995
6. Boyce GA, Boyce HW Jr: Esophagus: Anatomy and structural anomalies. In: Textbook of Gastroenterology, 2nd ed. T Yamada, DH Alpers, C Owyang, DW Powell, FE Silverstein (eds). Philadelphia, JB Lippincott, 1995, pp 1156-1174
7. Palmer ED: The hiatus hernia-esophagitis-esophageal stricture complex: Twenty-year prospective study. Am J Med 44:566-579, 1968
8. Barham CP, Gotley DC, Mills A, Alderson D: Oesophageal acid clearance in patients with severe reflux oesophagitis. Br J Surg 82:333-337, 1995
9. Hopwood D: Oesophageal defense mechanisms. Digestion 56:5-8, 1995
10. Brown CM, Rees WDW: Factors protecting the oesophagus against acid-mediated injury. Aliment Pharmacol Ther 9:251-262, 1995
11. Hirschowitz BI: A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101:1149-1158, 1991
12. 2 antagonists. Scand J Gastroenterol 27:449-452, 1992
13. Hirschowitz BI: Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls. Dig Dis Sci 41:1384-1391, 1996
14. Spechler SJ, Sperber H, Doos WG, et al: The prevalence of Barrett's esophagus in patients with chronic peptic esophageal strictures. Dig Dis Sci 28:769-774, 1983
15. Hirschowitz BI: Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer. Gastroenterology 86:843-851, 1984
16. Kirkpatrick PM Jr, Hirschowitz BI: Duodenal ulcer with unex-plained marked basal gastric acid hypersecretion. Gastroenterology 79:4-10, 1980
17. Hirschowitz BI, Groarke J: Vagal effects on acid and pepsin secretion and serum gastrin in duodenal ulcer and controls. Dig Dis Sci 38:1874-1884, 1993
18. Haggitt RC: Barrett's esophagus: Definition and histology. In: Accomplishments in Oncology. Premalignant Lesions of the Esophagus and Colon. BI Hirschowitz (ed). Philadelphia, JB Lippincott, 1989, pp 19-28
19. McClave SA, Boyce HW, Gottfried MR: Early diagnosis of columnar-lined esophagus: A new endoscopic diagnostic criterion. Gastrointest Endosc 33:413-416, 1987
20. 2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 106:907-915, 1994
21. Smith PM, Kerr GD, Cockel R, Ross BA, Hate CM, Brown P, Dronfield W, Green JRB, Hislop WS, Theodossi A, et al: A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Gastroenterology 107:1312-1318, 1994
22. Hirschowhz BI, Keeling D, Lewin M, Okabe S, Parsons M, Sewing K, Wallmark B, Sachs G: Pharmacological aspects of acid secretion. Dig Dis Sci 40:3S-23S, 1995
23. Korsten MA, Rosman AS, Fishhein S, et al: Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med 90:701-706, 1991
24. Helm JF, Dodds WJ, Pelc LR, et al: Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 310:284-288, 1984
25. Helm JF, Dodds WJ, Hogan WJ: Salivary responses to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology 93:1393-1397, 1987
26. Helm JF, Dodds WJ, Riedel DR, et al: Determinants of esophageal acid clearance in normal subjects. Gastroenterology 85:607-612, 1983
27. Mittal RK, Rochester DF, McCallum RW: Sphincteric action of the diaphragm during a relaxed LES in humans. Am J Physiol 256:6139-6144, 1989
28. Larrain A, Csendes A, Uribe P, et al: Manometric evaluation after posterior gastropexy for treatment of strictures of the esophagus secondary to reflux. Surg Gynecol Obstet 136:564-566, 1973
29. Berstad A, Weberg R, Froyshov I, et al: Relationship of hiatus hernia to reflux esophagitis. A prospective study of incidence using endoscopy. Scand J Gastroenterol 21:55, 1986
30. Hiatt GA: The roles of esophagoscopy vs radiography in diagnosing benign peptic esophageal strictures. Gastrointest Endosc 23:194-195, 1977
31. Mittal RK, Holloway R, Dent J: Effect of atropine on the frequency of reflux and transicnt lower esophageal sphincter relaxation in normal subjects. Gastroenterology 109:1547-1554, 1995
32. Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J: Transient lower esophageal sphincter relaxation. Gastroenterology 109:601-610, 1995
33. Baldi F, Ferrarini F, Longanesi A, et al: Oesophageal function before, during, and after healing of erosive oesophagitis. Gut 29:157-160, 1988
34. Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A: Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 91:897-904, 1986
35. Singh P, Adamopoulos A, Taylor RH, Colin-Jones DG: Ocsophugeal motor function before and after healing of oesophagitis. Gut 33:1590-1596, 1992
36. Hollwarth ME, Smith J, Kvietys PR, Granger DN: Esophageal blood How in the cat. Normal distribution and effects of acid perfusion. Gastroenterology 90:622-627, 1986
37. Lanas A, Sousa FL, Esteva F, Ortego J, Blas J, Sainz R: Aspirin (ASA) renders the esophageal mucosa more permeable to acid and pepsin in rabbits. Gastroenterology 104:A129, 1993
38. Bonavina L, DeMeester TR, McChesney L, et al: Pill-induced esophagitis. Ann Surg 206:173-183, 1987
39. Marks R, Richter JE, Lanas A, Hirsehowitz BI: High prevalence of aspirin use among patients with peptic esophageal strictures. Am J Gastroenterol 87:43A, 1992
40. Hirschowitz BI: Pepsin in the pathogenesis of peptic ulceration. In: Mechanisms of Peptic Ulcer Healing. F Halter, A Garner, GNJ Tytgat (eds). Dordrecht, The Netherlands, Kluwer Academic Publishers, 1990, pp 183-194
41. Sontag SJ, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM, McCullough A, Ippoliti AF, Richter JE, et al: Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The US multicenter study. Gastroenterology 102:208-212, 1992
42. Hetzel DJ: Controlled clinical trials of omeprazole in the long-term management of reflux disease. Digestion 51:49-58. 1992
43. 2-receptor antagonist therapy. Digestion 51:44-48, 1992
44. Chen YM, Gelland DW, Ott DJ, et al: Natural progression of the lower esophageal mucosal ring. Gastrointest Radiol 12:93-98, 1987
45. Wilkins WE, Ridley MG, Pozniak AL: Benign stricture of the oesophagus: Role of non-steroidal anti-inflammatory drugs. Gut 25:478-480, 1984
46. Weaver GA, Harper RL, Storey JA, Jenkins PL, Merrell NB: Nonsteroidal antiinflammatory drugs are associated with gastric outlet obstruction. J Clin Gastroenterol 20:196-198, 1995
47. van Gossum A, Zalcman M, Adler M, Peny MO, Houben JJ, Cremer M: Anorectal stenosis in patients with prolonged use of suppositories containing paracetamol and acetylsalieylic acid. Dig Dis Sci 38:1970-1977, 1993
48. 2 effects on stimulated normal human fibroblast cultures. Inflammopharmacology 2:377-387, 1994
49. Durant S, Duval D, Homo-Delarche F: Effect of exogenous prostaglandins and nonsteroidal anti-inflammatory agents on prostaglandin secretion and proliferation of mouse embryo fibroblasts in culture. Prostaglandin Leukot Essent Fatty Acids 38:1-8, 1989
50. Zamost BJ, Hirschberg J, Ippoliti AF, et al: Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology 92:421-428, 1987